ACMC
SLRN

AyurMaya Capital Management Company’s ACELYRIN SLRN Stock Holding History

AyurMaya Capital Management Company’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,334,735
Closed -$23.1M – 2
2025
Q1 		$23.1M Hold
9,334,735
– – 26.08% 2
2024
Q4 		$29.3M Hold
9,334,735
– – 25.94% 2
2024
Q3 		$46M Hold
9,334,735
– – 28.81% 2
2024
Q2 		$41.2M Hold
9,334,735
– – 22.53% 2
2024
Q1 		$63M Hold
9,334,735
– – 100% 1
2023
Q4 		$69.6M Hold
9,334,735
– – 100% 1
2023
Q3 		$94.9M Hold
9,334,735
– – 100% 1
2023
Q2 		$195M Buy
+9,334,735
New +$191M 100% 1

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AyurMaya Capital Management Company's SLRN Position: Q2 2025 in Review

AyurMaya Capital Management Company sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 9,334,735 shares — an estimated $23.1M sold.

AyurMaya Capital Management Company first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $195M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • AyurMaya Capital Management Company reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • AyurMaya Capital Management Company sold 9,334,735 ACELYRIN shares in Q2 2025, an estimated $23.1M.
  • AyurMaya Capital Management Company first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
  • AyurMaya Capital Management Company's ACELYRIN position peaked at $195M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on AyurMaya Capital Management Company's 13F filing for Q2 2025, filed 14 Aug 2025.